Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells

Medicina (Lithuania)

Volumn 50, Issue 4, 2014, Pages 237-244

  Pašukoniene, Vita ^a   Mlynska, Agata ^a   Steponkiene, Simona ^a   Poderys, Vilius ^a   Matulionyte, Marija ^a,b   Karabanovas, Vitalijus ^a   Statkute, Urte ^a   Purviniene, Rasa ^a   Kraśko, Jan Aleksander ^a   Jagminas, Arunas ^c   Kurtinaitiene, Marija ^c   Strioga, Marius ^a   Rotomskis, Ričardas ^a,b  

^a NATIONAL CANCER INSTITUTE   (Lithuania)

^b VILNIUS UNIVERSITY   (Lithuania)

^c CENTER FOR PHYSICAL SCIENCES AND TECHNOLOGY   (Lithuania)

Author keywords

Cancer stem like cells; Cytotoxicity; nanoparticles; Ovarian cancer; Pancreatic cancer; Superparamagnetic cobalt ferrite

Indexed keywords

COBALT; COBALT FERRITE; FERRIC ION; NANOPARTICLE;

CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; DRUG EFFECTS; FEMALE; FLOW CYTOMETRY; HUMAN; METABOLISM; OVARY TUMOR; PANCREAS TUMOR; PARTICLE SIZE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; COBALT; FEMALE; FERRIC COMPOUNDS; FLOW CYTOMETRY; HUMANS; NANOPARTICLES; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PARTICLE SIZE;

EID: 84923801929     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medici.2014.09.009     Document Type: Article

References (30)

1. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7(9):771-82.
2. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 2008;3(2):133-49.
3. Wang MD, Shin DM, Simons JW, Nie S. Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther 2007;7(6):833-7.
4. Clausell-Tormos J, Heeschen C. Pancreatic cancer stem cells as new targets for diagnostics and therapy. Else Kroner Fresen Symp 2011;2:116-34.
5. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988;168(2):297-301.
6. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175(2):494-8.
7. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26(18):3995-4021.
8. Mou Y, Hou Y, Chen B, Hua Z, Zhang Y, Xie H, et al. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide. Int J Nanomed 2011;6:2633-40.
9. Silva AC, Oliveira TR, Mamani JB, Malheiros SMF, Malavolta L, Pavon LF, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomed 2011;6:591-603.
10. Berry CC, Wells S, Charles S, Aitchison G, Curtis ASG. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 2004;25(23):5405-13.
11. Mahmoudi M, Simchi A, Milani AS, Stroeve P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 2009;336(2):510-8.
12. Singh N, Jenkins GJ, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 2010;1.
13. 4. J Appl Phys 2007;101(9).
14. Liu C, Zou BS, Rondinone AJ, Zhang J. Chemical control of superparamagnetic properties of magnesium and cobalt spinel ferrite nanoparticles through atomic level magnetic couplings. J Am Chem Soc 2000;122(26):6263-7.
15. 4 powders prepared at room temperature: variation with crystallite size. J Magn Magn Mater 2001;232(1-2):71-83.
16. Naseri MG, Saion EB, Ahangar HA, Shaari AH, Hashim M. Simple synthesis and characterization of cobalt ferrite nanoparticles by a thermal treatment method. J Nanomater 2010. http://dx.doi.org/10.1155/2010/907686. Article ID: 907686, 8 pages.
17. Deer EL, Gonzalez-Hernandez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, et al. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010;39(4):425-35.
18. Bao B, Azmi A, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, et al. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. J Biol Chem 2014;289(21):14520-33.
19. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009;28(2):209-18.
20. Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, et al. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 2009;27(33):5660-9.
21. Kurzeder C, Sauer G, Deissler H. Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy. Curr Cancer Drug Target 2006;6(3):207-27.
22. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 1981;17(2):1247.
23. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011;17(3):313-9.
24. Berry CC, Wells S, Charles S, Curtis ASG. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003;24(25):4551-7.
25. Mahmoudi M, Simchi A, Imani M, Shokrgozar MA, Milani AS, Hafeli UO, et al. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B Biointerfaces 2010;75(1):300-9.
26. Przybytkowski E, Behrendt M, Dubois D, Maysinger D. Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability. FEBS J 2009;276(21):6204-17.
27. Baumann M, Krause M, Hill R. Clonogens and cancer stem cells. Nat Rev Cancer 2008;8(12).
28. van der Gun BT, Melchers LJ, Ruiters MH, de Leij LF, McLaughlin PM, Rots MG. EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis 2010;31(11):1913-21.
29. Schafer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, et al. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 2007;244(2):514-23.
30. Balakumaran A, Pawelczyk E, Ren J, Sworder B, Chaudhry A, Sabatino M, et al. Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness". PLoS ONE 2010;5(7):e11462.